Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • Data Privacy
  • Français
  • my CNW 
    • Login
    • Register
  • Client Login 
    • Online Member Centre
    • Next Gen Communications Cloud
    • Cision Communications Cloud®
  • Sign Up
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
Advanced Search
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Canadian Federal Government
      • Canadian Municipal Government
      • Canadian Provincial Government
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

  • Advanced Search
  • Overview
  • Cision Communications Cloud®
  • Monitoring
  • Distribution
  • Multimedia
  • Guaranteed Paid Placement
  • AI Tools
  • IR
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Hamburger menu
  • Cision Canada
  • Send a Release
  • FR
    • Phone

    • 877-269-7890 from 8 AM - 10 PM ET

    • ALL CONTACT INFO
    • Contact Cision

      877-269-7890
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • Overview
  • Cision Communications Cloud®
  • Monitoring
  • Distribution
  • Multimedia
  • Guaranteed Paid Placement
  • AI Tools
  • IR
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR

Canadians hit and miss when it comes to understanding prescription pain medications Français


News provided by

Eli Lilly Canada Inc.

Oct 09, 2014, 07:00 ET

Share this article

Share toX

Share this article

Share toX

TORONTO, Oct. 9, 2014 /CNW/ - Canadians continue to buy into several myths surrounding prescription pain medications, according to just-released survey results.1  Commissioned by Eli Lilly Canada, the survey of 2,040 Canadians found that misunderstandings exist about this category of medicines.1

"The marketing of instant and complete relief for pain, combined with evidence of increased abuse of opioids, has unfortunately tainted the perception of Canadians when it comes to prescription pain medications," suggests Dr. Philip Baer from the Ontario Medical Association. "Canadians need to know that prescription medications with manageable side-effects do exist that can effectively address chronic pain within an acceptable time period, without an abuse potential."

Myth #1 – Prescription pain medications should work immediately

Unfortunately, Canadians believe in a "quick fix" myth. When asked how soon they would expect a prescription medication used to treat chronic pain to begin to work, two-thirds of surveyed Canadians (65%) strongly agree or somewhat agree they should begin to work immediately, within hours.1 According to Dr. Baer, Canadians need to be aware that relief from chronic pain requires a safe and effective treatment approach that can take some time.

"Medication is often a cornerstone of chronic pain management. It's understandable that people who are suffering want instant relief from their chronic pain, but it is a myth that all prescription pain medications work immediately and within hours," says Dr. Baer. "Many treatment options need more than a week to reach their full pain relieving effect, so those living with chronic pain need to be patient".

Myth #2 – Prescription pain medications are addictive

Concern about the potential for addiction is front and centre when it comes to Canadians' views about prescription pain medication.  In fact, six-in-ten surveyed Canadians (62%) strongly agree or somewhat agree that prescription pain medications are addictive.1

"This should come as no surprise," says Dr. Baer. "Over the past decade, increased abuse of and addiction to opioids, even when taken as prescribed, has emerged as a public health issue.  Unfortunately, this has created a fear mentality among Canadians that all prescription pain medications may be addictive.  There are safe and effective prescription pain medications that address specific types of chronic pain but without the dependence potential often associated with opioid use," says Dr. Baer.

According to the Centre for Addiction and Mental Health (CAMH)2, the risk of opioid abuse appears to be higher in people with a history of addiction. Addiction is when a drug becomes central to a person's thoughts, emotions and activities, and he or she feels a craving or compulsion to continue using the drug. This may or may not include physical dependence.

A study published in the journal Canadian Family Physician found that use of high-dose formulations of opioids jumped significantly in Canada between 2006 and 2011, despite guidelines advising doctors against giving such elevated doses to most patients.3,4

The findings are significant, because high-dose formulations of narcotic pain killing opioid drugs can increase the risk of trauma, accidental overdose and death.3

Myth #3 – Prescription pain medications will take away all of the pain

Despite a movement toward the use of medication as part of the equation in providing pain relief, some Canadians are still making the assumption that prescription medication will provide total relief. Almost a quarter of surveyed Canadians (23%) strongly agree or somewhat agree that prescription pain medication will take away all of the pain.1

Experts point out that pain medication can provide relief by reducing pain, but may not fully eliminate pain.5  That is why doctors are increasingly considering chronic pain a condition of its own requiring medication as well as complementary treatments, such as exercise, acupuncture, massage and biofeedback.6 

In fact, the Canadian Pain Coalition echoes this sentiment.  According to Lynn Cooper, President of the Canadian Pain Coalition, "following a pain management plan that includes multiple approaches and that addresses a patient's physical and emotional needs may help them feel a sense of control despite living with pain."

Understanding facts about pain

It is important that patients are aware of the facts associated with the use of prescription medications. For example, prescription medications are commonly associated with side effects.  When asked if they are concerned about the side-effects of prescription pain medications, six-in-ten Canadians who were surveyed (61%) strongly agree or somewhat agree with this statement.1  However, experts point out that many side effects can be managed, allowing patients to safely benefit from the medication.7

While Canadians understand that prescription pain medications are not risk free, they also recognize that the mind and the body are interconnected when it comes to chronic pain.

According to the survey, three-quarters of Canadians (73%) strongly agree or somewhat agree that the mind and the body each play a role when it comes to chronic pain.1   As experts point out and many Canadians agree, pain is affected by multiple factors at play in the nervous system.  Mood, past experiences and expectations can all change the way pain is interpreted at any given time.8   Negative emotions, including sadness and anxiety, for example, seem to aggravate chronic pain.6 

Get a pain management plan

If you live with chronic pain, it is important to talk to your doctor about your pain symptoms, safe and effective treatments options, and a pain management plan to help you better manage your pain so you can get on with life and enjoy the things you like to do.

According to Dr. Baer, "while knowing the facts about prescription pain medications is important, so is learning about the availability of other supportive therapies.  Following a pain management plan can help to regain a sense of control, despite living with chronic pain."

References
______________________________
1 This poll was conducted by Nielsen on behalf of Eli Lilly, using the teleVox telephone omnibus survey and was fielded from July 10, 2014 to July 20, 2014. A total of 2,040 completed surveys were collected from Canadians aged 18+, using random digit dialing (RDD).  The survey has a margin of error of +/- 2.2%, 19 times out of 20.
2 CAMH – Do you know…prescription opioids?  Available at: http://www.camh.ca/en/hospital/health_information/a_z_mental_health_and_addiction_information/oxycontin/Pages/opioids_dyk.aspx  Accessed September 9, 2014.
3 Canadian Family Physician – Trends in high-dose opioid prescribing in Canada.  Available at: http://www.cfp.ca/content/60/9/826.full.pdf+html Accessed September 16, 2014.
4 McMaster University – Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. Available at: http://nationalpaincentre.mcmaster.ca/opioid/cgop_b03_monitoring_long_term_opioid_therapy.html  Accessed September 17, 2014.
5 Webmd – When your pain medication isn't working.  Available at: http://www.webmd.com/pain-management/features/when-pain-medications-not-working  Accessed July 31, 2014.  
6 Webmd – Top causes of chronic pain.  Available at: http://www.webmd.com/pain-management/chronic-pain-11/causes-pain  Accessed July 31, 2014.
7 Webmd – Pain management health centers.  Available at:  http://www.webmd.com/pain-management/tc/pain-management-side-effects-of-pain-medicines   Accessed July 31, 2014.
8 About.com – How we feel pain. Available at: http://pain.about.com/od/whatischronicpain/a/feeling_pain.htm
Accessed July 31, 2014.

SOURCE: Eli Lilly Canada Inc.

OR TO BOOK AN INTERVIEW WITH AN EXPERT, PLEASE CONTACT: Lauren Harrison, Cohn & Wolfe, (416) 924-5700 ext. 4043, [email protected]; Helen Stone, Eli Lilly Canada Inc., (416) 693-3169, [email protected]

Modal title

Organization Profile

Eli Lilly Canada Inc.

    Also from this source

  • LILLY CANADA ANNOUNCES AVAILABILITY OF MOUNJARO® KWIKPEN® (TIRZEPATIDE INJECTION) IN ALL DOSES, ADVANCING CARE FOR ADULTS LIVING WITH TYPE 2 DIABETES

  • LILLY'S TIRZEPATIDE SUPERIOR TO WEGOVY® (SEMAGLUTIDE) IN HEAD-TO-HEAD TRIAL SHOWING AN AVERAGE WEIGHT LOSS OF 20.2% VS. 13.7%

  • Lilly Canada remains steadfast in commitment to access options for patients amidst controversial CDA-AMC recommendation for Ebglyss™ (lebrikizumab)

Contact Cision

  • 866-245-2317
    from 8 AM - 10 PM ET
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media

Products

  • Cision Communications Cloud®
  • Media Monitoring
  • Content Distribution
  • Multimedia Distribution
  • Measurement & Analytics
  • Investor Relations

About

  • About Cision Canada
  • About Cision
  • Media Partners
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Online Member Centre
  • Next Gen Communications Cloud
  • Cision Communications Cloud®
  • my CNW

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Centre
  • Next Gen Communications Cloud
  • Cision Communications Cloud
  • my CNW
877-269-7890
from 8 AM - 10 PM ET
  • Terms of Use
  • Information Security Policy
  • Site Map
  • Cookie Settings
  • Accessibility Statement
Copyright © 2025 CNW Group Ltd. All Rights Reserved. A Cision company.